What is it about?
A China-U.S. study led by scientists at China Pharmaceutical University (CPU) and Harvard University has identified a new small-molecule antagonist of the stimulator of interferon genes (STING) signaling pathway, SN-011, and shown it to be safe, effective and specific in STING-driven inflammatory diseases.
Featured Image
Photo by Jellybee on Unsplash
Why is it important?
SN-011 was demonstrated to inhibit activation of wild-type (WT) and SAVI-associated STING GOF mutants. SN-011 was not only well tolerated, but also shown to ameliorate autoimmune pathology and significantly prevent death in Trex1-deficient mice. It potentially could be improved for treating inflammatory and auto-immune diseases.
Perspectives
The SN-011 could be served as a starting point for developing drugs, which are instrumental for treating a broad range of inflammatory diseases, concerning various pathological organs
Chen Wang
China Pharmaceutical University
Read the Original
This page is a summary of: STING inhibitors target the cyclic dinucleotide binding pocket, Proceedings of the National Academy of Sciences, June 2021, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2105465118.
You can read the full text:
Contributors
The following have contributed to this page
